TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Impact of Supplementation With Dual Megadose of Vitamin A in the Post-partum About Vitamin A Levels in Breast Milk, Serum Levels of Vitamin A and Iron in the Binomial Mother-son and Growth and Morbidity of Children Under 6 Months
Brief Summary: The purpose of this study is to evaluate the effect of maternal supplementation with 400,000 IU of oral retinol palmitate in the post-partum, the nutritional situation of the binomial mother-child, on growth and morbidity of children in breastfeeding in the first six months of life.


Options:
A: Arm Label: A; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo | Arm Label: B; Type: EXPERIMENTAL; Interventions: Dietary Supplement: vitamin A | Intervention Type: DIETARY_SUPPLEMENT; Name: vitamin A; Assigned to Arm(s): B | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo; Assigned to Arm(s): A
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Vitamin A or Beta-Carotene Supplements | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Vitamin A or Beta-Carotene Supplements | Arm Label: 3; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Vitamin A or Beta-Carotene Supplements | Intervention Type: DIETARY_SUPPLEMENT; Name: Vitamin A or Beta-Carotene Supplements; Assigned to Arm(s): 1, 2, 3
C: Arm Label: Orange maize; Type: EXPERIMENTAL; Interventions: Other: Orange maize feeding | Arm Label: Blue vitamin A group; Type: ACTIVE_COMPARATOR; Interventions: Other: Vitamin A supplement | Arm Label: White; Type: PLACEBO_COMPARATOR; Interventions: Other: Oil only | Intervention Type: OTHER; Name: Orange maize feeding; Assigned to Arm(s): Orange maize | Intervention Type: OTHER; Name: Vitamin A supplement; Assigned to Arm(s): Blue vitamin A group | Intervention Type: OTHER; Name: Oil only; Assigned to Arm(s): White
D: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Biological: Vitamin A | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Biological: Vitamin A | Intervention Type: BIOLOGICAL; Name: Vitamin A; Assigned to Arm(s): 1, 2

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Impact of Supplementation With Dual Megadose of Vitamin A in the Post-partum About Vitamin A Levels in Breast Milk, Serum Levels of Vitamin A and Iron in the Binomial Mother-son and Growth and Morbidity of Children Under 6 Months
Brief Summary: The purpose of this study is to evaluate the effect of maternal supplementation with 400,000 IU of oral retinol palmitate in the post-partum, the nutritional situation of the binomial mother-child, on growth and morbidity of children in breastfeeding in the first six months of life.


Options:
A: Arm Label: Boys 1; Type: ACTIVE_COMPARATOR; Interventions: Biological: OPV | Arm Label: Boys 2; Type: EXPERIMENTAL; Interventions: Biological: OPV plus BCG | Arm Label: Girls 1; Type: ACTIVE_COMPARATOR; Interventions: Biological: OPV | Arm Label: Girls 2; Type: EXPERIMENTAL; Interventions: Biological: OPV plus BCG | Intervention Type: BIOLOGICAL; Name: OPV; Assigned to Arm(s): Boys 1 | Intervention Type: BIOLOGICAL; Name: OPV plus BCG; Assigned to Arm(s): Boys 2 | Intervention Type: BIOLOGICAL; Name: OPV; Assigned to Arm(s): Girls 1 | Intervention Type: BIOLOGICAL; Name: OPV plus BCG; Assigned to Arm(s): Girls 2
B: Intervention Type: DRUG; Name: Vitamin A; Assigned to Arm(s): N/A
C: Arm Label: Low birth-weight cohort; Type: N/A; Interventions: N/A
D: Arm Label: A; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo | Arm Label: B; Type: EXPERIMENTAL; Interventions: Dietary Supplement: vitamin A | Intervention Type: DIETARY_SUPPLEMENT; Name: vitamin A; Assigned to Arm(s): B | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo; Assigned to Arm(s): A

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Impact of Strengthened Health Extension Program and Community Based Treatment of Neonatal Infections on Neonatal Mortality in Oromia and South Nation and Nationalities & People Region(SNNPR), Ethiopia
Brief Summary: The purpose of the study is to determine whether community based management of infections with antibiotics administered by health extension workers reduce all cause mortality in neonates after the first day of life compared to current MOH IMNCI model of referral to hospital


Options:
A: Arm Label: Arm1; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Other: Community Based | Intervention Type: OTHER; Name: Community Based; Assigned to Arm(s): 2
B: Arm Label: Home-based counselling visits by volunteers; Type: EXPERIMENTAL; Interventions: Behavioral: Home-based counselling | Arm Label: Standard care through existing health system; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Home-based counselling; Assigned to Arm(s): Home-based counselling visits by volunteers
C: Arm Label: Good household prenatal practice (GHPP); Type: EXPERIMENTAL; Interventions: Behavioral: Good household prenatal practice | Arm Label: Care seeking (CS); Type: EXPERIMENTAL; Interventions: Behavioral: Care seeking | Arm Label: Full bank of SMS; Type: EXPERIMENTAL; Interventions: Behavioral: Full bank of SMS | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Good household prenatal practice; Assigned to Arm(s): Good household prenatal practice (GHPP) | Intervention Type: BEHAVIORAL; Name: Care seeking; Assigned to Arm(s): Care seeking (CS) | Intervention Type: BEHAVIORAL; Name: Full bank of SMS; Assigned to Arm(s): Full bank of SMS
D: Arm Label: Neonatal Kit; Type: EXPERIMENTAL; Interventions: Device: Neonatal Kit | Arm Label: Neonatal Stimulation; Type: EXPERIMENTAL; Interventions: Behavioral: Neonatal Stimulation | Arm Label: Neonatal Kit and Neonatal Stimulation; Type: EXPERIMENTAL; Interventions: Device: Neonatal Kit, Behavioral: Neonatal Stimulation | Arm Label: Control (Standard Care); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Neonatal Kit; Assigned to Arm(s): Neonatal Kit, Neonatal Kit and Neonatal Stimulation | Intervention Type: BEHAVIORAL; Name: Neonatal Stimulation; Assigned to Arm(s): Neonatal Kit and Neonatal Stimulation, Neonatal Stimulation

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Impact of Strengthened Health Extension Program and Community Based Treatment of Neonatal Infections on Neonatal Mortality in Oromia and South Nation and Nationalities & People Region(SNNPR), Ethiopia
Brief Summary: The purpose of the study is to determine whether community based management of infections with antibiotics administered by health extension workers reduce all cause mortality in neonates after the first day of life compared to current MOH IMNCI model of referral to hospital


Options:
A: Arm Label: intervention; Type: EXPERIMENTAL; Interventions: Other: Neonatal resuscitation protocol | Arm Label: control; Type: ACTIVE_COMPARATOR; Interventions: Other: Standard of care | Intervention Type: OTHER; Name: Neonatal resuscitation protocol; Assigned to Arm(s): intervention | Intervention Type: OTHER; Name: Standard of care; Assigned to Arm(s): control
B: Arm Label: Arm1; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Other: Community Based | Intervention Type: OTHER; Name: Community Based; Assigned to Arm(s): 2
C: Arm Label: Amoxicillin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Amoxicillin | Arm Label: Sugar Syrup; Type: PLACEBO_COMPARATOR; Interventions: Drug: Sugar Syrup | Intervention Type: DRUG; Name: Amoxicillin; Assigned to Arm(s): Amoxicillin | Intervention Type: DRUG; Name: Sugar Syrup; Assigned to Arm(s): Sugar Syrup
D: Arm Label: Proactive Community Case Management (ProCCM); Type: EXPERIMENTAL; Interventions: Other: Proactive Community Case Management, Other: Removal of point-of-care user fees, Other: Infrastructure improvements at primary health centre, Other: Training of primary health centre staff | Arm Label: integrated Community Case Management (iCCM); Type: ACTIVE_COMPARATOR; Interventions: Other: Integrated Community Case Management, Other: Removal of point-of-care user fees, Other: Infrastructure improvements at primary health centre, Other: Training of primary health centre staff | Intervention Type: OTHER; Name: Proactive Community Case Management; Assigned to Arm(s): Proactive Community Case Management (ProCCM) | Intervention Type: OTHER; Name: Integrated Community Case Management; Assigned to Arm(s): integrated Community Case Management (iCCM) | Intervention Type: OTHER; Name: Removal of point-of-care user fees; Assigned to Arm(s): Proactive Community Case Management (ProCCM), integrated Community Case Management (iCCM) | Intervention Type: OTHER; Name: Infrastructure improvements at primary health centre; Assigned to Arm(s): Proactive Community Case Management (ProCCM), integrated Community Case Management (iCCM) | Intervention Type: OTHER; Name: Training of primary health centre staff; Assigned to Arm(s): Proactive Community Case Management (ProCCM), integrated Community Case Management (iCCM)

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Impact of Strengthened Health Extension Program and Community Based Treatment of Neonatal Infections on Neonatal Mortality in Oromia and South Nation and Nationalities & People Region(SNNPR), Ethiopia
Brief Summary: The purpose of the study is to determine whether community based management of infections with antibiotics administered by health extension workers reduce all cause mortality in neonates after the first day of life compared to current MOH IMNCI model of referral to hospital


Options:
A: Arm Label: Arm1; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Other: Community Based | Intervention Type: OTHER; Name: Community Based; Assigned to Arm(s): 2
B: Arm Label: procaine penicillin and gentamicin; Type: ACTIVE_COMPARATOR; Interventions: Drug: procaine penicillin and gentamicin, Drug: procaine penicillin, gentamicin, amoxicillin | Arm Label: Amoxicillin and gentamicin; Type: EXPERIMENTAL; Interventions: Drug: amoxicillin and gentamicin, Drug: procaine penicillin, gentamicin, amoxicillin | Arm Label: procaine penicillin, gentamicin, and amoxicillin; Type: EXPERIMENTAL; Interventions: Drug: procaine penicillin, gentamicin, amoxicillin | Intervention Type: DRUG; Name: procaine penicillin and gentamicin; Assigned to Arm(s): procaine penicillin and gentamicin | Intervention Type: DRUG; Name: amoxicillin and gentamicin; Assigned to Arm(s): Amoxicillin and gentamicin | Intervention Type: DRUG; Name: procaine penicillin, gentamicin, amoxicillin; Assigned to Arm(s): Amoxicillin and gentamicin, procaine penicillin and gentamicin, procaine penicillin, gentamicin, and amoxicillin
C: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Gentamicin & Amoxicillin x 7days | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Penicillin & gentamicin x 2 d + Amoxicillin X 5 d | Arm Label: 3; Type: ACTIVE_COMPARATOR; Interventions: Drug: Standard reference therapy | Intervention Type: DRUG; Name: Gentamicin & Amoxicillin x 7days; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Penicillin & gentamicin x 2 d + Amoxicillin X 5 d; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: Standard reference therapy; Assigned to Arm(s): 3
D: Intervention Type: BEHAVIORAL; Name: Improved management of severe neonatal infections; Assigned to Arm(s): N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Comparing Pump vs. Subcutaneous Injection Delivery of PTH 1-34 in the Management of Chronic Hypoparathyroidism
Brief Summary: This study will evaluate the safety, biological activity, and pharmacokinetics of PTH delivered by subcutaneous injection compared with an infusion pump. We anticipate pump delivery of PTH will be more physiologic because it mimics normal parathyroid gland secretion of PTH. We expect that pump delivery will simultaneously normalize blood and urine calcium, phosphorus and magnesium levels with minimal or no fluctuations throughout the day. Pump therapy will require lower PTH doses and should normalize markers of bone turnover. We expect the improved metabolic control during pump therapy will be especially evident in patients with more severe forms of hypoparathyrodism where there is an unmet need for improved therapy.


Options:
A: Arm Label: 25 µg dose; Type: EXPERIMENTAL; Interventions: Drug: NPSP558 | Arm Label: 50 µg dose; Type: EXPERIMENTAL; Interventions: Drug: NPSP558 | Intervention Type: DRUG; Name: NPSP558; Assigned to Arm(s): 25 µg dose, 50 µg dose
B: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: 50, 75, 100 mcg NPSP558; Type: EXPERIMENTAL; Interventions: Drug: NPSP558 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: NPSP558; Assigned to Arm(s): 50, 75, 100 mcg NPSP558
C: Intervention Type: DRUG; Name: Synthetic Human Parathyroid Hormone 1-34; Assigned to Arm(s): N/A
D: Arm Label: a: PTH (1-84) 100 ug s.c.inj. once a day; Type: ACTIVE_COMPARATOR; Interventions: Drug: a: PTH (1-84) | Arm Label: b: placebo 100 ug s.c. inj. once a day; Type: PLACEBO_COMPARATOR; Interventions: Drug: b:placebo | Intervention Type: DRUG; Name: a: PTH (1-84); Assigned to Arm(s): a: PTH (1-84) 100 ug s.c.inj. once a day | Intervention Type: DRUG; Name: b:placebo; Assigned to Arm(s): b: placebo 100 ug s.c. inj. once a day

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Phase II Study of Combination Chemotherapy With Epirubicin , Cisplatin and Capecitabine (ECX) or Cisplatin and Capecitabine (CX) in Advanced Gastric Cancer
Brief Summary: Recently, 3-drug (ECX) and 2-drug (CX) combination chemotherapy involving capecitabine showed promising results in randomized clinical trials for advanced gastric cancer (AGC). The objective of the study is to evaluate the safety and activity of ECX and CX combination chemotherapy given as first-line therapy for AGC.


Options:
A: Arm Label: ECX; Type: EXPERIMENTAL; Interventions: Drug: Epirubicin, Drug: Cisplatin, capecitabine | Arm Label: CX; Type: ACTIVE_COMPARATOR; Interventions: Drug: Cisplatin, capecitabine | Intervention Type: DRUG; Name: Epirubicin; Assigned to Arm(s): ECX | Intervention Type: DRUG; Name: Cisplatin, capecitabine; Assigned to Arm(s): CX, ECX
B: Arm Label: Everolimus + BSC; Type: EXPERIMENTAL; Interventions: Drug: Everolimus, Drug: Best Supportive Care (BSC) | Arm Label: Placebo + BSC; Type: PLACEBO_COMPARATOR; Interventions: Drug: Everolimus placebo, Drug: Best Supportive Care (BSC) | Intervention Type: DRUG; Name: Everolimus; Assigned to Arm(s): Everolimus + BSC | Intervention Type: DRUG; Name: Everolimus placebo; Assigned to Arm(s): Placebo + BSC | Intervention Type: DRUG; Name: Best Supportive Care (BSC); Assigned to Arm(s): Everolimus + BSC, Placebo + BSC
C: Arm Label: EOX; Type: ACTIVE_COMPARATOR; Interventions: Other: EOX | Arm Label: mDCF; Type: ACTIVE_COMPARATOR; Interventions: Other: mDCF | Intervention Type: OTHER; Name: EOX; Assigned to Arm(s): EOX | Intervention Type: OTHER; Name: mDCF; Assigned to Arm(s): mDCF
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: docetaxel + S-1 | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: S-1 | Intervention Type: DRUG; Name: docetaxel + S-1; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: S-1; Assigned to Arm(s): 2

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Use of Mesalamine Pellet Formulation 1.5G QD to Maintain Remission From Mild to Moderate Ulcerative Colitis
Brief Summary: The purpose of this study is to compare the maintenance of mild to moderate ulcerative colitis remission with six months of treatment with 1.5 grams of mesalamine pellets each day versus placebo.


Options:
A: Arm Label: Dex 21-P; Type: EXPERIMENTAL; Interventions: Drug: Dex 21-P | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Dex 21-P; Assigned to Arm(s): Dex 21-P | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Granulated mesalamine | Intervention Type: DRUG; Name: Granulated mesalamine; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 2
C: Arm Label: 1. Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Basiliximab | Arm Label: 2. 40 mg Simulect; Type: EXPERIMENTAL; Interventions: Drug: Basiliximab | Intervention Type: DRUG; Name: Basiliximab; Assigned to Arm(s): 1. Placebo, 2. 40 mg Simulect
D: Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Biological: sterile saline for injection | Arm Label: 1; Type: EXPERIMENTAL; Interventions: Biological: MDX-1100 | Intervention Type: BIOLOGICAL; Name: sterile saline for injection; Assigned to Arm(s): 2 | Intervention Type: BIOLOGICAL; Name: MDX-1100; Assigned to Arm(s): 1

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Population-Based Intervention to Reduce Prehospital Delays in Patients With Stroke and Transient Ischaemic Attack
Brief Summary: In patients with acute stroke, systemic thrombolysis needs to be administered within three hours of symptom onset. The aim of the present study was to reduce prehospital delays in a population-based intervention.The intervention consisted of an educational letter indicating stroke symptoms and emphasizing the importance of calling the emergency medical services (EMS). The investigators additionally included a bookmark and sticker with the EMS telephone number. A total of 75,720 inhabitants received the intervention. Between 2004 and 2005, 741 patients with cerebrovascular events were admitted from the control areas (n=24) and 647 from the intervention areas (n=24).


Options:
A: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: interactive educational program | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: usual medical care | Intervention Type: BEHAVIORAL; Name: interactive educational program; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: usual medical care; Assigned to Arm(s): 2
B: Arm Label: Intervention group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: educational material | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: educational material; Assigned to Arm(s): Intervention group
C: Arm Label: Hip Hop Stroke educational program; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Hip Hop Stroke educational program | Arm Label: Nutrition Education program; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Nutrition Education program | Intervention Type: BEHAVIORAL; Name: Hip Hop Stroke educational program; Assigned to Arm(s): Hip Hop Stroke educational program | Intervention Type: BEHAVIORAL; Name: Nutrition Education program; Assigned to Arm(s): Nutrition Education program
D: Arm Label: Current Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Care Transition Intervention; Type: EXPERIMENTAL; Interventions: Other: Structured Telephone / Remote Outpatient Monitoring | Intervention Type: OTHER; Name: Structured Telephone / Remote Outpatient Monitoring; Assigned to Arm(s): Care Transition Intervention

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Finhyst 2006: Incidence, Methods, Complications and Effect on Quality of Life of Hysterectomies in Finland in 2006
Brief Summary: The purpose of this study is to analyze prospectively all hysterectomies performed in Finland for benign indications including all 46 public hospitals performing hysterectomies and also 7 private clinics. Hypothesis is that vaginal and laparoscopic hysterectomies are safe and cost-effective methods of hysterectomy.


Options:
A: Arm Label: I; Type: ACTIVE_COMPARATOR; Interventions: Procedure: laparoscopy | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Procedure: vaginal | Arm Label: 3; Type: ACTIVE_COMPARATOR; Interventions: Procedure: abdominal | Intervention Type: PROCEDURE; Name: laparoscopy; Assigned to Arm(s): I | Intervention Type: PROCEDURE; Name: vaginal; Assigned to Arm(s): 2 | Intervention Type: PROCEDURE; Name: abdominal; Assigned to Arm(s): 3
B: Arm Label: Robot assisted laparoscopic hysterectomy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Robot assisted laparoscopic hysterectomy | Arm Label: Abdominal hysterectomy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Abdominal hysterectomy | Intervention Type: PROCEDURE; Name: Abdominal hysterectomy; Assigned to Arm(s): Abdominal hysterectomy | Intervention Type: PROCEDURE; Name: Robot assisted laparoscopic hysterectomy; Assigned to Arm(s): Robot assisted laparoscopic hysterectomy
C: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Conventional Laparoscopic Hysterectomy | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Robot-assisted (Da Vinci®) laparoscopic hysterectomy | Intervention Type: PROCEDURE; Name: Conventional Laparoscopic Hysterectomy; Assigned to Arm(s): 1 | Intervention Type: PROCEDURE; Name: Robot-assisted (Da Vinci®) laparoscopic hysterectomy; Assigned to Arm(s): 2
D: Arm Label: VH; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Vaginal hysterectomy | Arm Label: LAVH; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Laparoscopic assisted vaginal hysterectomy | Intervention Type: PROCEDURE; Name: Vaginal hysterectomy; Assigned to Arm(s): VH | Intervention Type: PROCEDURE; Name: Laparoscopic assisted vaginal hysterectomy; Assigned to Arm(s): LAVH

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Dexmedetomidine vs. Midazolam for Facilitating Extubation in Medical and Surgical ICU Patients: A Randomized, Double-Blind Study
Brief Summary: The purpose of this randomized, double-blind study is to evaluate the utility, safety, and cost of transitioning benzodiazepine sedation to dexmedetomidine in medical or surgical intensive care unit (ICU) patients requiring sedation when tracheal extubation is nearing. Fifty medical or surgical ICU patients requiring sedation with existing benzodiazepine therapy and qualifying for daily awakenings will be randomized in a double-blind manner to receive additional midazolam or dexmedetomidine.


Options:
A: Arm Label: Midazolam; Type: ACTIVE_COMPARATOR; Interventions: Drug: Midazolam | Arm Label: Dexmedetomidine; Type: EXPERIMENTAL; Interventions: Drug: Dexmedetomidine | Intervention Type: DRUG; Name: Midazolam; Assigned to Arm(s): Midazolam | Intervention Type: DRUG; Name: Dexmedetomidine; Assigned to Arm(s): Dexmedetomidine
B: Arm Label: No sedatation intervention; Type: OTHER; Interventions: Procedure: Sedation or no sedation during mechanical ventilation | Intervention Type: PROCEDURE; Name: Sedation or no sedation during mechanical ventilation; Assigned to Arm(s): No sedatation intervention
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Dexmedetomidine | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Propofol | Intervention Type: DRUG; Name: Dexmedetomidine; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Propofol; Assigned to Arm(s): 2
D: Arm Label: Dexmedetomidine; Type: EXPERIMENTAL; Interventions: Drug: Dexmedetomidine HCL Injection | Arm Label: Midazolam; Type: ACTIVE_COMPARATOR; Interventions: Drug: Midazolam Injection | Intervention Type: DRUG; Name: Dexmedetomidine HCL Injection; Assigned to Arm(s): Dexmedetomidine | Intervention Type: DRUG; Name: Midazolam Injection; Assigned to Arm(s): Midazolam

Answer: A